Articles | April 27, 2022

Model Pension Plan's Funded Status Rises

During the first quarter of 2022, the funded status of the model pension plan examined in each issue of Prism rose by 6 percentage points, to 107 percent, as illustrated in the graph below.

This increase in funded status is primarily attributable to a 11 percent decrease in liabilities, partially offset by a 6 percent decrease in assets.

Get the full data

Man Examining Data Download Now

Prism Review of First Quarter 2022

Aspects of investment performance that contributed to the loss in asset value

Equity and fixed income returns were negative across the board during Q1, as Russia’s invasion of Ukraine and relentlessly increasing inflation readings globally dominated headlines.

U.S. equity markets had their worst performance since Q1 2020 (when COVID-19 lockdowns began), with March providing slightly positive returns, which could not offset the negative returns during the first two months of the quarter.

Fixed income returns were poor both domestically and internationally as interest rates soared across the globe.

Examine your own DB plan’s experience

Plan sponsors should examine changes in their own DB plans’ assets, liabilities and funded ratios from the vantage point of both accounting and funding metrics.

We can help employers project their DB plans’ funded ratios with a complete view of the range of a plan’s possible future statuses, presenting early warning signs of potential challenges.

See more insights

A Man In His 50S Is Holding Pill Bottles While Searching For Information Online

Guidance Clarifies RDS and Creditable Coverage Calculation

Sponsors of retiree health plans: Learn key aspects on how the CMS final guidance on changes to Medicare Part D prescription drug program impacts you.
Arab Couple Smiling And Doing Their Finances

Employees' Financial Well-Being Matters to Them and Your ROI

Learn how a financial well-being program can help your people and your bottom line ― and how to use a scorecard to ensure that it’s working.
Lab Technicians

Spotlight on Gene Therapies in Q2 2024 Trends

Health plan sponsors: Ready for gene therapies? We explore four solutions that support reimbursement and patient access to these high-cost treatments.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.